Polymer Factory announces one of the single largest orders for SpheriCal® today from a leading biopharma company in US. The customer is a key player and a global leader in life science, diagnostics and applied markets.
The materials purchased will be used by the customer for product evaluation purposes, a process that holds potential for further collaboration and expanded business opportunities upon successful evaluation. We are delighted to support our customer with highly sophisticated SpheriCal® calibration standards. This is an ongoing collaboration, and we are optimistic about additional opportunities arising from this joint venture. This order marks a milestone for SpheriCal®, reflecting its strategic value of strengthening relationships with key players in the Mass Spectrometry space for life science applications.
About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 12th of February 2025.
For more information, please contact:
Mats Wallnér, Acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g., a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com
Comments